NO20014341L - Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger - Google Patents
Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetningerInfo
- Publication number
- NO20014341L NO20014341L NO20014341A NO20014341A NO20014341L NO 20014341 L NO20014341 L NO 20014341L NO 20014341 A NO20014341 A NO 20014341A NO 20014341 A NO20014341 A NO 20014341A NO 20014341 L NO20014341 L NO 20014341L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- fatty acids
- polyunsaturated fatty
- cosmetic
- dissolution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
Hensikten med foreliggende oppfinnelse er en vandig oppløsning som omfatter minst et oljeaktig stoff valgt fra flerumettede fettsyrer og salter, estere og triglyserider av flerumettede fettsyrer, hvor de nevnte stoff(er) er i form av et inklusjonskompleks i y-syklodekstrin.Det oljeaktige stoffet(ene) kan være valgt fra arakidonsyre (AA), eikosapentaensyre (EPA), dokosaheksaensyre (DHA) og triglyserider derav såvel som fra fiskeoljer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9902881A FR2790758A1 (fr) | 1999-03-09 | 1999-03-09 | Solubilisation d'acides gras polyinsatures et de leurs derives par formation de complexes d'inclusion avec une cyclodextrine et leur utilisation dans des compositions pharmaceutiques, cosmetiques ou alimentaires |
PCT/FR2000/000560 WO2000053637A1 (fr) | 1999-03-09 | 2000-03-07 | COMPLEXES D'INCLUSION D'ACIDES GRAS POLYINSATURES ET DE LEURS DERIVES AVEC LA η-CYCLODEXTRINE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014341L true NO20014341L (no) | 2001-09-06 |
NO20014341D0 NO20014341D0 (no) | 2001-09-06 |
Family
ID=9542970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014341A NO20014341D0 (no) | 1999-03-09 | 2001-09-06 | Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1165620A1 (no) |
JP (1) | JP2002539138A (no) |
CA (1) | CA2366719A1 (no) |
FR (1) | FR2790758A1 (no) |
NO (1) | NO20014341D0 (no) |
WO (1) | WO2000053637A1 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10253042A1 (de) | 2002-11-14 | 2004-06-03 | Wacker-Chemie Gmbh | Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F |
ES2209658B1 (es) * | 2002-12-05 | 2005-10-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia. |
FR2850040B1 (fr) * | 2003-01-20 | 2005-03-11 | Centre Nat Rech Scient | Systemes pour microencapsulation et leurs applications |
US7105195B2 (en) | 2003-07-25 | 2006-09-12 | General Mills, Inc. | Reduced trans fat product |
US20040180125A1 (en) * | 2003-03-11 | 2004-09-16 | Plank David W. | Cyclodextrin-containing compositions and methods |
US7335386B2 (en) | 2003-07-30 | 2008-02-26 | Gerneral Mills, Inc. | Method for preventing acrylamide formation in food products and food intermediates |
EP1637134A4 (en) * | 2003-06-20 | 2010-01-27 | Mochida Pharm Co Ltd | COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICES |
EP2049083A2 (en) * | 2006-12-27 | 2009-04-22 | Cargill, Incorporated | Stabilisation by preparing cyclodextrin inclusion complexes |
FR2915901A1 (fr) * | 2007-05-07 | 2008-11-14 | In Cyclo Soc Par Actions Simpl | Composition homogene et stable, riche en substances oleagineuses a base d'un produit laitier, son procede de preparation et ses utilisations. |
GB0710439D0 (en) * | 2007-05-31 | 2007-07-11 | Uni I Oslo | Oral dosage form |
GB0808479D0 (en) * | 2008-05-09 | 2008-06-18 | Uni I Oslo | Topical compositions |
FR3048177B1 (fr) * | 2016-02-25 | 2020-10-30 | Fabre Pierre Dermo Cosmetique | Composition cosmetique biphase et son utilisation par application topique |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5813541A (ja) * | 1981-07-16 | 1983-01-26 | Kureha Chem Ind Co Ltd | エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物 |
JPS5941395A (ja) * | 1982-09-01 | 1984-03-07 | マルハ株式会社 | 魚油類の安定化方法 |
JPS6034156A (ja) * | 1983-08-08 | 1985-02-21 | Hayashibara Biochem Lab Inc | エイコサペンタエン酸包接化合物及びこれを含有した飲食物 |
IT1243192B (it) * | 1990-08-09 | 1994-05-24 | Staroil Ltd | Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine |
JPH0725816A (ja) * | 1993-07-08 | 1995-01-27 | Yoshihisa Matsuda | ポリエン酸類の包接化合物 |
-
1999
- 1999-03-09 FR FR9902881A patent/FR2790758A1/fr active Pending
-
2000
- 2000-03-07 EP EP00909441A patent/EP1165620A1/fr not_active Withdrawn
- 2000-03-07 CA CA002366719A patent/CA2366719A1/fr not_active Abandoned
- 2000-03-07 WO PCT/FR2000/000560 patent/WO2000053637A1/fr not_active Application Discontinuation
- 2000-03-07 JP JP2000604072A patent/JP2002539138A/ja not_active Withdrawn
-
2001
- 2001-09-06 NO NO20014341A patent/NO20014341D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2366719A1 (fr) | 2000-09-14 |
JP2002539138A (ja) | 2002-11-19 |
EP1165620A1 (fr) | 2002-01-02 |
FR2790758A1 (fr) | 2000-09-15 |
NO20014341D0 (no) | 2001-09-06 |
WO2000053637A1 (fr) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Calder | Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases | |
JP5159321B2 (ja) | クリプテコディニウム属からの抗酸化抽出物の製造および使用 | |
NO991635L (no) | Farmas°ytisk preparat omfattende eikospentaensyre og/eller stearidonsyre | |
NO20014341L (no) | Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger | |
CY1105119T1 (el) | Χρηση πολυακορεστων λιπαρων οξεων για την πρωτογενη προληψη σοβαρων καρδιαγγειακων επεισοδιων | |
AU2003238240A1 (en) | ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE | |
WO2007017240A3 (en) | Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids | |
KR940018090A (ko) | 트리글리세라이드 | |
EE200300599A (et) | Koensüüm Q ja EPA või muu asendamatu rasvhape | |
KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
EE05148B1 (et) | Rasvhapete terapeutilised kombinatsioonid | |
DE69622722T2 (de) | Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms | |
IL210233A (en) | Formulation of omega-3 fatty acid containing epa and dha and no other active ingredients other than omega-3 fatty acids | |
EP2510927A3 (en) | Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage | |
EP2430926A3 (en) | Use of DPA(n-6) oils in infant formula | |
JP2013508296A5 (no) | ||
WO2008018043A3 (en) | Methods of improving bone health and muscle health | |
EP1698685A4 (en) | FAT COMPOSITION | |
RU2010103038A (ru) | Композиции для персонального ухода, обладающие ослабленным раздражающим действием на глаза | |
Leray | Introduction to lipidomics: from bacteria to man | |
UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
AU2441400A (en) | Stabilized lipidic composition, method for the preparation thereof and nutritional product containing the same | |
RS52735B (en) | APPLICATION OF A COMBINATION CONTAINING L-CARNITINE OR ALKANOIL L-CARNITINE, OIL-SOLUBLE OIL-BENZOQUINON AND OMEGA-3-POLYESATURATED FATTY ACID FOR PREPARATION OF NUTRITION OR MEDICINAL PRODUCTS | |
NO20071180L (no) | Delta 6-desaturase-gener og anvendelser derav | |
TW360545B (en) | Dermatologic preparation |